NAS:RXRX (USA)
Â
Class A
$
7.21
+0.22 (+3.15%)
12:24 PM EST
Business Description
Recursion Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US75629V1044
Share Class Description:
RXRX: Class ADescription
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.72 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 3.55 | |||||
| Beneish M-Score | -3.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 91.6 | |||||
| 3-Year EBITDA Growth Rate | -26.8 | |||||
| 3-Year EPS without NRI Growth Rate | -27.6 | |||||
| 3-Year FCF Growth Rate | -46 | |||||
| Future 3-5Y Total Revenue Growth Rate | 39.69 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.57 | |||||
| 9-Day RSI | 52.24 | |||||
| 14-Day RSI | 51.49 | |||||
| 6-1 Month Momentum % | -35.59 | |||||
| 12-1 Month Momentum % | -44.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.35 | |||||
| Quick Ratio | 4.35 | |||||
| Cash Ratio | 3.93 | |||||
| Days Payable | 33.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.5 | |||||
| Shareholder Yield % | -13.05 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.48 | |||||
| Operating Margin % | -610.16 | |||||
| Net Margin % | -584.75 | |||||
| FCF Margin % | -519.55 | |||||
| ROE % | -78.32 | |||||
| ROA % | -56.47 | |||||
| ROIC % | -130.11 | |||||
| ROC (Joel Greenblatt) % | -281.61 | |||||
| ROCE % | -66.12 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 27.28 | |||||
| PB Ratio | 3.8 | |||||
| Price-to-Tangible-Book | 4.57 | |||||
| EV-to-EBIT | -5.29 | |||||
| EV-to-EBITDA | -5.76 | |||||
| EV-to-Revenue | 31.28 | |||||
| EV-to-FCF | -6.02 | |||||
| Price-to-Net-Current-Asset-Value | 7.61 | |||||
| Price-to-Net-Cash | 9.15 | |||||
| Earnings Yield (Greenblatt) % | -18.9 | |||||
| FCF Yield % | -12.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RXRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Recursion Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 64.601 | ||
| EPS (TTM) ($) | -1.55 | ||
| Beta | 0.98 | ||
| Volatility % | 77.18 | ||
| 14-Day RSI | 51.49 | ||
| 14-Day ATR ($) | 0.687921 | ||
| 20-Day SMA ($) | 6.943 | ||
| 12-1 Month Momentum % | -44.77 | ||
| 52-Week Range ($) | 5.6 - 15.74 | ||
| Shares Outstanding (Mil) | 390.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Recursion Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Recursion Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Recursion Pharmaceuticals Inc Frequently Asked Questions
What is Recursion Pharmaceuticals Inc(RXRX)'s stock price today?
The current price of RXRX is $7.21. The 52 week high of RXRX is $15.74 and 52 week low is $5.60.
When is next earnings date of Recursion Pharmaceuticals Inc(RXRX)?
The next earnings date of Recursion Pharmaceuticals Inc(RXRX) is 2025-02-27 Est..
Does Recursion Pharmaceuticals Inc(RXRX) pay dividends? If so, how much?
Recursion Pharmaceuticals Inc(RXRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers